Introduction 68
Phthalates are a family of chemicals whose structure only varies in the length (1 to > 10 69 6 respectively), and additional cord blood sample was obtained at delivery. 118 119
Phthalate Metabolite Measurements 120
As described by Huang et al. (2016) The concentrations of the QC samples were to be less than 2 times the method detection limit. 134
The QC sample for each sample was spiked in pooled urine samples with a mixture of 135 phthalate metabolite standards (20-50 ng/mL). The relative percent difference for the QC 136 sample as well as its recovery were to be less than ±30%. 137 138
Serum Thyroid Hormones and Urinary Creatinine Analysis 139
Serum thyroid function and urinary creatinine levels were measured by a Taiwan 
Statistical Analysis 151
Descriptive statistics on participant demographics were tabulated with the distribution of 152 phthalate metabolites concentrations and thyroid hormones. The levels of hormones and 153 phthalate metabolites were transformed using the natural logarithm (ln) to meet the normality 154 assumption. The mixed models were applied to compare these differences in urinary 155 phthalate metabolite levels or thyroid hormones from different study visit. The associations 156 between urinary phthalate metabolites and thyroid hormone levels were assessed using a 157 mixed-model repeated measures analysis after adjustment for fixed covariates, such as 158 maternal age at enrollment (continuous variable), gestational age at sample collection 159 (categorical variable), urinary creatinine (continuous variable), and plasma TBG (continuous 160 variable). These covariates were selected on the basis of previous studies (Boas et al. 2010, 161 Meeker and Ferguson 2011) (such as maternal age at enrollment, gestational age at sample 162 collection and urinary creatinine) and a 10% change-in-estimated criterion (Rothman et al. 163 2008) and Akaike's information criterion (AIC) (such as plasma TBG ). These models 164 considered the participants as random effects, as well as maternal age at enrollment, 165 gestational age at sample collection, urinary creatinine, and plasma TBG as fixed effect and 166 the first-order autoregressive and variance components were constructed as covariance8 structures. The models were selected on the basis of Akaike's information criterion (AIC). 168
Residual and influence analyses were conducted ( Figure S1 ). The associations between 169 urinary phthalate metabolites levels and thyroid function were not simultaneously adjusted 170 for other phthalate metabolites. In our subsequent analyses, we examined the associations 171 between urinary phthalate metabolites and thyroid hormone levels at visits 1-3 by using 172 linear regression models. These models were adjusted for maternal age at enrollment, urinary 173 creatinine, and plasma TBG levels. A two-sided P < 0.05 was considered statistically 174 significant. All statistical analyses were performed using SAS (Version 9.1.3; SAS Institute 175
Inc., Cary, NC, USA). 176 177
Results 178

Participant Characteristics 179
The mean age of all participants was 35 years (standard deviation: 3.5); they had high 180 education levels ( significantly lower than those at visit 1, but TBG levels were significantly higher. In addition, 196 the serum levels of TSH at visit 3 were significantly higher than those at visit 1. In addition, 197
Most of urinary phthalate metabolites levels were significantly correlated within the same 198 study visit in pregnant women. However, few of urinary phthalate metabolites levels from 199 different study visit among pregnant women were significantly correlated (Table S2) . 200 201
Associations between Urinary Phthalate Metabolites and Thyroid Function 202
The associations of thyroid hormones with urinary phthalate metabolites in pregnant women, 203 as determined using linear mixed models, are shown in Table 3 . We found that urinary MiBP 204 levels were negatively associated with serum TSH levels (β = −0.065, 95% confidence 205 positive associations were observed between urinary MEP and free T4 levels (β = 0.014, 95% 213 CI: −0.001, 0.028, p=0.063). We have assessed these associations as well while considering 214 the other phthalate metabolites levels in the models, indicating that these results were similar 215 to those without adjusting for other phthalate metabolites levels (Table S3) . 216
Associations between Urinary Phthalate Metabolites and Thyroid Function, 218
Stratified by Study Visit 219
To determine the possible window of exposure to phthalates on thyroid function in pregnant 220 women, we further examined the associations between urinary phthalate metabolites and 221 thyroid hormone levels at the study visits (Figure 1 ). Urinary MEOHP, MECCP, and DEHPm 222 levels were negatively associated with TSH levels at visit 2. Urinary MMP levels at visit 1 223 and urinary MiBP, MnBP, and ΣDBPm levels at visit 2 were positively associated with T3 224 levels. Moreover, negative associations were observed between urinary MEHHP, MEOHP, 225 MECCP, and DEHPm levels and T3 levels at visit 3. Urinary MnBP levels were negatively 226 associated with T4 levels at visit 1, and urinary MCMHP levels were positively associated 227
with T4 levels at visit 1. Urinary MEP and MiBP levels were positively associated with free 228 T4 levels at visit 1. 229
In addition, we found that maternal MnBP levels andΣDBPm levels at the visit 2 were 230 positively associated with the T3 levels in cord serum (β = 0.054, 95% CI: 0.008, 0.1 for 231
MnBP; β = 0.067, 95% CI: 0.003, 0.131 for ΣDBPm) (Table 4) . Positive relations between 232 maternal ΣDBPm levels at the visit 2 and the free T4 levels in cord serum were observed (β = 233 0.031, 95% CI: 0.001, 0.062). These effects in the models were still similar after adjusting 234 maternal thyroid hormone levels (Table S4) . 235
Discussion 236
Our repeated measurement analyses revealed that urinary MiBP and MEOHP levels were 237 negatively associated with TSH levels, urinary MECPP and MCMHP levels were inversely 238 associated with T3 levels, and urinary MiBP levels were positively associated with free T4 239 levels in pregnant women. In a cross-sectional analysis stratified by study visit, the 240 magnitude and direction of these associations differed with the gestational trimester. Several 241 metabolites, such as MEOHP, MECCP, and DEHPm, were inversely associated with TSH at 242 visit 2 and with T3 levels at visit 3. We observed that T4 levels at visit 1 were associated 243 negatively with urinary MnBP levels and positively with urinary MCMHP levels. At visit 1, 244 urinary MEP and MiBP levels were positively associated with free T4 levels. These results 245 revealed that exposure to environmental phthalates can influence thyroid function in pregnant 246
women. Furthermore, our findings indicate that different windows of exposure to phthalates 247 during gestation can alter levels of thyroid hormones, and the timing of phthalate exposure 248 may be an important determinant of susceptibility to thyroid disruption in pregnant women. between urinary phthalate metabolites and thyroid hormones levels in 439 pregnant women 252 during gestation. Similar to our results, they reported inverse associations between urinary 253 MEHP and MiBP levels and TSH levels. However, in contrast to our observations, they did 254 not observe negative associations between urinary MECCP levels and T3 levels or positive 255 associations between urinary MiBP levels and free T4 levels. In an earlier study, no 256 statistically significant associations were observed between urinary phthalate metabolites and 257 serum TSH or free T4 levels in a repeated measures analysis of two study visits in Puerto 258
Rico (Johns et al. 2015) . However, in a cross-sectional analysis, urinary MiBP levels were 259 found to be significantly and positively associated with free T4 levels at a median gestation 260 period of 18 weeks, and these results are in agreement with our own results in the present 261 study. Johns et al. (2016) observed similar associations at a median gestation period of 18 262 weeks, but these were non-significant. 263 264 Several cross-sectional epidemiological studies have explored the potential effects of 265 phthalates on thyroid function in pregnant women. We observed significant inverse 266 associations between urinary MnBP and T4 levels at visit 1, whereas Huang et al. (2007) 267 observed similar associations between urinary MBP and T4 levels at a mean gestation period 268 of 27.9 weeks. Furthermore, we found that urinary MEOHP, MECCP, and DEHPm levels 269 were negatively associated with TSH levels at visit 2 (median: 26 gestational weeks). 270
Similarly, Johns et al. (2016) reported inverse associations between these phthalate 271 metabolites and TSH levels at a median gestation period of 10 weeks, whereas Kuo et al. 272 (2015) observed the same associations but in the third trimester. However, Yao et al. (2016) 273 reported positive associations between urinary MEHP and MEHHP and TSH levels in 2521 274 pregnant women at <14 gestational weeks in China. These discrepancies among the studies 275 can be because of differences in the population size, sample collection timing, phthalate 276 exposure profiles, population demographic characteristics, and study design. lower plasma T4 concentrations in rats fed with DEHP-contaminated products than in 291 controls (Hinton et al. 1986; Howarth et al. 2001; Poon et al. 1997) . Moreover, 292 histopathological changes in rats' thyroid after DEHP exposure have been reported to 293 correspond to thyroid hyperactivity (Howarth et al. 2001; Mitchell et al. 1985) . In their vitro 294 study, Wenzel et al. (2005) demonstrated that phthalates can alter the transcriptional activity 295 of the sodium-iodide symporter and cause changes in the iodide uptake of thyroid follicular 296 cells. Furthermore, phthalates can affect thyroid hormones not only through biosynthesis and 297 biotransport but also through biotransformation and metabolism (Liu et al. 2015) . Recent 298 animal experiments have suggested that DEHP can influence thyroid hormones by disturbing 299 the hypothalamus-pituitary-thyroid axis (Dong et al. 2017 ) and activating the Ras-Akt-300 thyrotropin-releasing hormone receptor pathway and inducing hepatic enzymes (Ye et al. 301 2017) . 302
303
Each organ system has a different developmental trajectory, and the sensitive window for 304 exposure to cause toxicity varies during tissue development in pregnancy. Therefore, the 305 effects of in utero exposure depend not only on the type and dose of the chemical but also on 306 the exposure time (Schug et al. 2011) . In early pregnancy (before 20 gestational weeks), the 307 mother is the major source of thyroid hormones for the fetus, and in later pregnancy (after 20 308 gestational weeks), fetal thyroid function starts and maternal thyroid hormones are still 309 pregnant women can have important influences on fetal health. Higher maternal free T4 levels 311 in early pregnancy was reported to be associated with lower birth weight and increased risk 312 of small-for-gestational age birth (Medici et al. 2012 ). In particular, in the present study, two 313 phthalate metabolites were positively associated with free T4 levels at visit 1 (median: 18 314 gestational weeks). 315
In the present study, we found that the T3 and free T4 levels in cord serum were positively 316 associated with maternalΣDBPm levels at the visit 2 (median: 26 weeks gestation). However, 317 indicated that the effects of maternal urinary phthalate metabolites before second trimester 325 may be crucial to the homeostasis of fetal thyroid hormone. Because of the limited samples in 326 cord serum in the present study, future large-scale studies are needed to address these 327
associations. 328 329
The study has several limitations. First, we did not collect information on the iodine or 330 selenium status of our participants, which may be critical because deficiencies in these trace 331 elements can impair normal thyroid function (Zimmermann and Kohrle 2002). However, no 332 participant reported having any thyroid-related disease. Moreover, previous studies have 333 indicated that iodine excretion negligibly affects the significant associations between 334 phthalate metabolites and thyroid hormones among a representative sample of adult men andwomen in the United States (Mendez and Eftim 2012). Second, we conducted numerous 336 comparisons and determined that some observed associations could have been chance events. 337
We did not perform adjustment for multiple comparisons because available methods (e.g., 338
Bonferroni adjustment) are often too conservative because of the underlying assumptions of 339 independence and increased probability of type 2 errors, thus potentially masking truly 340 important differences (Perneger 1998 b Active smoker was defined as someone who consumed a cigarette >1 time per day.
c Drank alcohol was defined as someone who consumed >100 ml of alcohol per week.
d Have ever consumed DEHP-tainted products means before a DEHP episode (May 2011) e Have ever taken means ever consumed the following nutritional supplements during the past 1 month. Cross-sectional analysis: adjusted regression coefficient and 95% CI for change in serum TSH (A), T3 (B), T4 (C), free T4 (D) levels in relation to unit-increased in Ln-phthalate metabolites (ng/mL).
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